A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä
Minimal clinically important difference and minimal detectable change of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) amongst patients with chronic musculoskeletal pain (2020)
Katajapuu, N., Heinonen, A., & Saltychev, M. (2020). Minimal clinically important difference and minimal detectable change of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) amongst patients with chronic musculoskeletal pain. Clinical Rehabilitation, 34(12), 1506-1511. https://doi.org/10.1177/0269215520942573
JYU-tekijät tai -toimittajat
Julkaisun tiedot
Julkaisun kaikki tekijät tai toimittajat: Katajapuu, Niina; Heinonen, Ari; Saltychev, Mikhail
Lehti tai sarja: Clinical Rehabilitation
ISSN: 0269-2155
eISSN: 1477-0873
Julkaisuvuosi: 2020
Ilmestymispäivä: 27.07.2020
Volyymi: 34
Lehden numero: 12
Artikkelin sivunumerot: 1506-1511
Kustantaja: SAGE Publications
Julkaisumaa: Britannia
Julkaisun kieli: englanti
DOI: https://doi.org/10.1177/0269215520942573
Julkaisun avoin saatavuus: Avoimesti saatavilla
Julkaisukanavan avoin saatavuus: Osittain avoin julkaisukanava
Julkaisu on rinnakkaistallennettu (JYX): https://jyx.jyu.fi/handle/123456789/71270
Tiivistelmä
The aim of this study is to estimate a minimal clinically important difference (MCID) and a minimal detectable change (MDC) of the 12-item WHODAS 2.0 amongst patients with chronic musculoskeletal pain.
Design:
Cross-sectional cohort study.
Setting:
Outpatient Physical and Rehabilitation Medicine clinic.
Subjects:
A total of 1988 consecutive patients with musculoskeletal pain.
Interventions:
A distribution-based approach was employed to estimate a minimal clinically important difference, a minimal detectable change, and a minimal detectable percent change (MDC%).
Results:
The mean age of the patients was 48 years, and 65% were women. The average intensity of pain was 6,3 (2.0) points (0–10 numeric rating scale) and the mean WHODAS 2.0 total score was 13 (9) points out of 48. The minimal clinically important difference ranged between 3.1 and 4.7 points. The minimal detectable change was 8.6 points and minimal detectable % change was unacceptably high 66%.
Conclusions:
Amongst patients with chronic musculoskeletal pain, the 12-item WHODAS 2.0 demonstrated a high minimal detectable change of almost nine points. As the minimal detectable change exceeded the level of minimal clinically important difference, nine points were considered to be the amount of change perceived by a respondent as clinically significant.
YSO-asiasanat: tuki- ja liikuntaelimet; kipu
Vapaat asiasanat: WHODAS; minimal clinically important difference; minimal detectable change; musculoskeletal pain
Liittyvät organisaatiot
OKM-raportointi: Kyllä
Raportointivuosi: 2020
JUFO-taso: 2
